Security key
45258H106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 570,198
- Total 13F value
- $5,878,740
- Share change
- +113,324
- SEC-reported price per share
- $10.31
- Number of holders
- 13
- Value change
- +$1,168,434
- Number of buys
- 8
- Number of sells
- 2
- Shares outstanding
- 69,928,708
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
13
Top holders
10
IMMX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Ownership snapshot
Top reported holders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
29 May 2026
13D/G
13F
Lead comparable stake: 13%
13D/G row: Janus Henderson Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Janus Henderson Group Ltd. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
Janus Henderson Group Ltd.
13%
Saturn V Capital Management LP
7%
MILLENNIUM MANAGEMENT LLC
3.3%
EVENTIDE ASSET MANAGEMENT, LLC
3.6%
VANGUARD CAPITAL MANAGEMENT LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd. |
13D/G
13F
JANUS HENDERSON GROUP PLC · Company
|
13%
|
$96,907,203
9,090,732 shares
|
+$45,717,862 | 29 May 2026 |
| Saturn V Capital Management LP |
13F
13D/G
Company
|
7%
from 13D/G
|
$33,648,559
3,693,585 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
3.3%
|
$16,959,438
1,750,200 shares
|
-$10,291,071 | 31 Mar 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
3.6%
|
$23,221,563
2,549,019 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
2.6%
|
$16,288,625
1,787,994 shares
|
— | 31 Mar 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
2.3%
|
$14,954,538
1,641,552 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
570,198
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q2 2026 holders
13
Holder diff
-18
| Investor | Q3 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend